RSV Diagnostics Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

1 RESEARCH SCOPE

1.1 Research Product Definition

1.2 Research Segmentation

1.2.1 Product Type

1.2.2 Main product Type of Major Players

1.3 Demand Overview

1.4 Research Methodology

2 GLOBAL RSV DIAGNOSTICS INDUSTRY

2.1 Summary about RSV Diagnostics Industry

2.2 RSV Diagnostics Market Trends

2.2.1 RSV Diagnostics Production & Consumption Trends

2.2.2 RSV Diagnostics Demand Structure Trends

2.3 RSV Diagnostics Cost & Price

3 MARKET DYNAMICS

3.1 Manufacturing & Purchasing Behavior in 2020

3.2 Market Development under the Impact of COVID-19

3.2.1 Drivers

3.2.2 Restraints

3.2.3 Opportunity

3.2.4 Risk

4 GLOBAL MARKET SEGMENTATION

4.1 Region Segmentation (2017 to 2021f)

4.1.1 North America (U.S., Canada and Mexico)

4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)

4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)

4.1.4 South America (Brazil,, Argentina, Rest of Latin America)

4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)

4.2 Product Type Segmentation (2017 to 2021f)

4.2.1 Kits and Assays 

4.2.2 Instruments 

4.2.3 Other 

4.3 Consumption Segmentation (2017 to 2021f)

4.3.1 Hospitals & Clinics 

4.3.2 Clinical Laboratories 

4.3.3 Homecare

5 NORTH AMERICA MARKET SEGMENT

5.1 Region Segmentation (2017 to 2021f)

5.1.1 U.S.

5.1.2 Canada

5.1.3 Mexico

5.2 Product Type Segmentation (2017 to 2021f)

5.2.1 Kits and Assays 

5.2.2 Instruments 

5.2.3 Other 

5.3 Consumption Segmentation (2017 to 2021f)

5.3.1 Hospitals & Clinics 

5.3.2 Clinical Laboratories 

5.3.3 Homecare

5.4 Impact of COVID-19 in North America

6 EUROPE MARKET SEGMENTATION

6.1 Region Segmentation (2017 to 2021f)

6.1.1 Germany

6.1.2 UK

6.1.3 France

6.1.4 Italy

6.1.5 Rest of Europe

6.2 Product Type Segmentation (2017 to 2021f)

6.2.1 Kits and Assays 

6.2.2 Instruments 

6.2.3 Other 

6.3 Consumption Segmentation (2017 to 2021f)

6.3.1 Hospitals & Clinics 

6.3.2 Clinical Laboratories 

6.3.3 Homecare

6.4 Impact of COVID-19 in Europe

7 ASIA-PACIFIC MARKET SEGMENTATION

7.1 Region Segmentation (2017 to 2021f)

7.1.1 China

7.1.2 India

7.1.3 Japan

7.1.4 South Korea

7.1.5 Southeast Asia

7.1.6 Australia

7.1.7 Rest of Asia Pacific

7.2 Product Type Segmentation (2017 to 2021f)

7.2.1 Kits and Assays 

7.2.2 Instruments 

7.2.3 Other 

7.3 Consumption Segmentation (2017 to 2021f)

7.3.1 Hospitals & Clinics 

7.3.2 Clinical Laboratories 

7.3.3 Homecare

7.4 Impact of COVID-19 in Europe

8 SOUTH AMERICA MARKET SEGMENTATION

8.1 Region Segmentation (2017 to 2021f)

8.1.1 Brazil

8.1.2 Argentina

8.1.3 Rest of Latin America

8.2 Product Type Segmentation (2017 to 2021f)

8.2.1 Kits and Assays 

8.2.2 Instruments 

8.2.3 Other 

8.3 Consumption Segmentation (2017 to 2021f)

8.3.1 Hospitals & Clinics 

8.3.2 Clinical Laboratories 

8.3.3 Homecare

8.4 Impact of COVID-19 in Europe

9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION

9.1 Region Segmentation (2017 to 2021f)

9.1.1 GCC

9.1.2 North Africa

9.1.3 South Africa

9.1.4 Rest of Middle East and Africa

9.2 Product Type Segmentation (2017 to 2021f)

9.2.1 Kits and Assays 

9.2.2 Instruments 

9.2.3 Other 

9.3 Consumption Segmentation (2017 to 2021f)

9.3.1 Hospitals & Clinics 

9.3.2 Clinical Laboratories 

9.3.3 Homecare

9.4 Impact of COVID-19 in Europe

10 COMPETITION OF MAJOR PLAYERS

10.1 Brief Introduction of Major Players

10.1.1 bioM?rieux 

10.1.2 Abbott 

10.1.3 Roche 

10.1.4 BD 

10.1.5 Thermo Fisher 

10.1.6 Luminex 

10.1.7 Danaher 

10.1.8 Biocartis 

10.1.9 Hologic

10.2 RSV Diagnostics Sales Date of Major Players (2017-2020e)

10.2.1 bioM?rieux 

10.2.2 Abbott 

10.2.3 Roche 

10.2.4 BD 

10.2.5 Thermo Fisher 

10.2.6 Luminex 

10.2.7 Danaher 

10.2.8 Biocartis 

10.2.9 Hologic

10.3 Market Distribution of Major Players

10.4 Global Competition Segmentation

11 MARKET FORECAST

11.1 Forecast by Region

11.2 Forecast by Demand

11.3 Environment Forecast

11.3.1 Impact of COVID-19

11.3.2 Geopolitics Overview

11.3.3 Economic Overview of Major Countries

12 REPORT SUMMARY STATEMENT

Table RSV Diagnostics Product Type Overview

Table RSV Diagnostics Product Type Market Share List

Table RSV Diagnostics Product Type of Major Players

Table Brief Introduction of bioM?rieux 

Table Brief Introduction of Abbott 

Table Brief Introduction of Roche 

Table Brief Introduction of BD 

Table Brief Introduction of Thermo Fisher 

Table Brief Introduction of Luminex 

Table Brief Introduction of Danaher 

Table Brief Introduction of Biocartis 

Table Brief Introduction of Hologic

Table Products & Services of bioM?rieux 

Table Products & Services of Abbott 

Table Products & Services of Roche 

Table Products & Services of BD 

Table Products & Services of Thermo Fisher 

Table Products & Services of Luminex 

Table Products & Services of Danaher 

Table Products & Services of Biocartis 

Table Products & Services of Hologic

Table Market Distribution of Major Players

Table Global Major Players Sales Revenue (Million USD) 2017-2020e

Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e

Table Global RSV Diagnostics Market Forecast (Million USD) by Region 2021f-2026f

Table Global RSV Diagnostics Market Forecast (Million USD) Share by Region 2021f-2026f

Table Global RSV Diagnostics Market Forecast (Million USD) by Demand 2021f-2026f

Table Global RSV Diagnostics Market Forecast (Million USD) Share by Demand 2021f-2026f